Rüegg Group
Peer reviewed articles
Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system
Furrer, M. and Altermatt, H. J. and Ris, H. B. and Althaus, U. and Ruegg, C. and Lienard, D. and Lejeune, F. J.,
7 Suppl 2
, S43–9
| Article
Efficiency of recombinant human TNF in human cancer therapy
Lejeune, F. J. and Lienard, D. and Matter, M. and Ruegg, C.,
6
, 6
| Article
Consensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, Patrycja and Alitalo, Kari and Allen, Elizabeth and Anisimov, Andrey and Aplin, Alfred C. and Auerbach, Robert and Augustin, Hellmut G. and Bates, David O. and van Beijnum, Judy R. and Bender, R. Hugh F. and Bergers, Gabriele and Bikfalvi, Andreas and Bischoff, Joyce and Bock, Barbara C. and Brooks, Peter C. and Bussolino, Federico and Cakir, Bertan and Carmeliet, Peter and Castranova, Daniel and Cimpean, Anca M. and Cleaver, Ondine and Coukos, George and Davis, George E. and De Palma, Michele and Dimberg, Anna and Dings, Ruud P. M. and Djonov, Valentin and Dudley, Andrew C. and Dufton, Neil P. and Fendt, Sarah-Maria and Ferrara, Napoleone and Fruttiger, Marcus and Fukumura, Dai and Ghesquiere, Bart and Gong, Yan and Griffin, Robert J. and Harris, Adrian L. and Hughes, Christopher C. W. and Hultgren, Nan W. and Iruela-Arispe, M. Luisa and Irving, Melita and Jain, Rakesh K. and Kalluri, Raghu and Kalucka, Joanna and Kerbel, Robert S. and Kitajewski, Jan and Klaassen, Ingeborg and Kleinmann, Hynda K. and Koolwijk, Pieter and Kuczynski, Elisabeth and Kwak, Brenda R. and Marien, Koen and Melero-Martin, Juan M. and Munn, Lance L. and Nicosia, Roberto F. and Noel, Agnes and Nurro, Jussi and Olsson, Anna-Karin and Petrova, Tatiana V. and Pietras, Kristian and Pili, Roberto and Pollard, Jeffrey W. and Post, Mark J. and Quax, Paul H. A. and Rabinovich, Gabriel A. and Raica, Marius and Randi, Anna M. and Ribatti, Domenico and Ruegg, Curzio and Schlingemann, Reinier O. and Schulte-Merker, Stefan and Smith, Lois E. H. and Song, Jonathan W. and Stacker, Steven A. and Stalin, Jimmy and Stratman, Amber N. and Van de Velde, Maureen and van Hinsbergh, Victor W. M. and Vermeulen, Peter B. and Waltenberger, Johannes and Weinstein, Brant M. and Xin, Hong and Yetkin-Arik, Bahar and Yla-Herttuala, Seppo and Yoder, Mervin C. and Griffioen, Arjan W.,
21.3
, 425–532
| Article
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
Alday-Parejo, B. and Stupp, R. and Ruegg, C.,
11.7
| Article
PI3Kgamma activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity
Breasson, L. and Becattini, B. and Sardi, C. and Molinaro, A. and Zani, F. and Marone, R. and Botindari, F. and Bousquenaud, M. and Ruegg, C. and Wymann, M. P. and Solinas, G.,
10.488
| Article
Assessment of microvascular perfusion changes in a rat breast tumor model using SonoVue to monitor the effects of different anti-angiogenic therapies
Broillet, A. and Hantson, J. and Ruegg, C. and Messager, T. and Schneider, M.,
12 Suppl 1
, S28–33
| Article
Characterization and In Vivo Validation of a Three-Dimensional Multi-Cellular Culture Model to Study Heterotypic Interactions in Colorectal Cancer Cell Growth, Invasion and Metastasis
Cattin, S. and Ramont, L. and Ruegg, C.,
6
, 97
| Article
β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4
D’Agostino, Gianluca and Artinger, Marc and Locati, Massimo and Perez, Laurent and Legler, Daniel F. and Bianchi, Marco E. and Rüegg, Curzio and Thelen, Marcus and Marchese, Adriano and Rocchi, Marco B. L. and Cecchinato, Valentina and Uguccioni, Mariagrazia,
11
| Article
Modulation of cdk2, cyclin D1, p16INK4a, p21WAF and p27Kip1 expression in endothelial cells by TNF/IFN gamma
Dormond, O. and Lejeune, F. J. and Ruegg, C.,
22.6
, 3159–63
| Article
Complete amino acid sequence of an integrin beta subunit (beta 7) identified in leukocytes
Erle, D. J. and Ruegg, C. and Sheppard, D. and Pytela, R.,
266.17
, 11009–16
| Article
MAGI1 Mediates eNOS Activation and NO Production in Endothelial Cells in Response to Fluid Shear Stress
Ghimire, K. and Zaric, J. and Alday-Parejo, B. and Seebach, J. and Bousquenaud, M. and Stalin, J. and Bieler, G. and Schnittler, H. J. and Ruegg, C.,
8.5
| Article
Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering
Gundersen, D. and Tran-Thang, C. and Sordat, B. and Mourali, F. and Ruegg, C.,
158.3
, 1051–60
| Article
Expressed isolated integrin beta1 subunit cytodomain induces endothelial cell death secondary to detachment
Hasmim, M. and Vassalli, G. and Alghisi, G. C. and Bamat, J. and Ponsonnet, L. and Bieler, G. and Bonnard, C. and Paroz, C. and Oguey, D. and Ruegg, C.,
94.5
, 1060–70
| Article
Induction of transendothelial migration in normal and malignant human T lymphocytes
Hauzenberger, D. and Hultenby, K. and Sumitran, S. and Ruegg, C. and Klominek, J.,
20.4
, 2601–11
| Article
Recombinant human tumor necrosis factor: an efficient agent for cancer treatment
Lejeune, F. J. and Ruegg, C.,
93.8
, E90–100
| Article
Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy
Lohri, C. and Schaltegger, C. S. and M, Van Den Broek and Wenger, R. H. and Ruegg, C. and Fink, D. and Fehr, M. K. and Knuth, A. and Zweifel, M.,
34.9
, 4693–9
| Article
Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1
Luethy, A. and Stenner, F. and Lohri, C. and Muller, C. and Samaras, P. and Steiner, R. and Van Den Broek, M. and Mischo, A. and Renner, C. and Knuth, A. and Ruegg, C. and Wenger, R. H. and Zweifel, M.,
31.10
, 3115–24
| Article
Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes
Marazzi, S. and Blum, S. and Hartmann, R. and Gundersen, D. and Schreyer, M. and Argraves, S. and von Fliedner, V. and Pytela, R. and Ruegg, C.,
161.1
, 138–47
| Article
A rational and iterative process for targeted nanoparticle design and validation
Rodriguez-Lorenzo, L. and Rafiee, S. D. and Reis, C. and Milosevic, A. and Moore, T. L. and Balog, S. and Rothen-Rutishauser, B. and Ruegg, C. and Petri-Fink, A.,
171
, 579–589
| Article
Dual CSF1R inhibition and CD40 activation demonstrates anti-tumor activity in a 3D macrophage- HER2+ breast cancer spheroid model
Rodriguez-Perdigon, Manuel and Haeni, Laetitia and Rothen-Rutishauser, Barbara and Rüegg, Curzio,
11
| Article
Anti-angiogenic therapies in cancer: achievements and open questions
Ruegg, C. and Mutter, N.,
94.9
, 753–62
| Article
Death to endothelial cells, death to melanoma?
Ruegg, C. and Oguey, D. and Lejeune, F.,
9.1
, 2–3
| Article
Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. Evidence for distinct endocytic routing of CD4 and CD3
Ruegg, C. L. and Rajasekar, S. and Stein, B. S. and Engleman, E. G.,
267.26
, 18837–43
| Article
Omics meets hypothesis-driven research. Partnership for innovative discoveries in vascular biology and angiogenesis
Ruegg, C. and Tissot, J. D. and Farmer, P. and Mariotti, A.,
100.5
, 738–46
| Article
Suppression of tumor angiogenesis by nonsteroidal anti-inflammatory drugs: a new function for old drugs
Ruegg, C. and Dormond, O.,
1
, 808–11
| Article
Vascular integrins: therapeutic and imaging targets of tumor angiogenesis
Ruegg, C. and Alghisi, G. C.,
180
, 83–101
| Article
Inhibition of host NOX1 blocks tumor growth and enhances checkpoint inhibitor-based immunotherapy
Stalin, J. and Garrido-Urbani, S. and Heitz, F. and Szyndralewiez, C. and Jemelin, S. and Coquoz, O. and Ruegg, C. and Imhof, B. A.,
2.4
| Article
Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2
Stoeck, M. and Ruegg, C. and Miescher, S. and Carrel, S. and Cox, D. and Von Fliedner, V. and Alkan, S.,
143.10
, 3258–65
| Article
PKB/Akt-dependent regulation of inflammation in cancer
Tang, F. and Wang, Y. and Hemmings, B. A. and Ruegg, C. and Xue, G.,
48
, 62–69
| Article
The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells
Alghisi, G. C. and Ponsonnet, L. and Ruegg, C.,
4.2
, e4449
| Article
Vascular integrins in tumor angiogenesis: mediators and therapeutic targets
Alghisi, G. C. and Ruegg, C.,
13.2
, 113–35
| Article
Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent Mkl1 signaling
Asparuhova, M. B. and Secondini, C. and Ruegg, C. and Chiquet-Ehrismann, R.,
9.8
, 1510–27
| Article
Fragment N2, a caspase-3-generated RasGAP fragment, inhibits breast cancer metastatic progression
Barras, D. and Lorusso, G. and Lhermitte, B. and Viertl, D. and Ruegg, C. and Widmann, C.,
135.1
, 242–7
| Article
Inhibition of cell migration and invasion mediated by the TAT-RasGAP317-326 peptide requires the DLC1 tumor suppressor
Barras, D. and Lorusso, G. and Ruegg, C. and Widmann, C.,
33.44
, 5163–72
| Article
Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage
Baruthio, F. and Quadroni, M. and Ruegg, C. and Mariotti, A.,
8.22
, 4733–47
| Article
Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt
Bezzi, M. and Hasmim, M. and Bieler, G. and Dormond, O. and Ruegg, C.,
278.44
, 43603–14
| Article
Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survival
Bieler, G. and Hasmim, M. and Monnier, Y. and Imaizumi, N. and Ameyar, M. and Bamat, J. and Ponsonnet, L. and Chouaib, S. and Grell, M. and Goodman, S. L. and Lejeune, F. and Ruegg, C.,
26.39
, 5722–32
| Article
Obesity promotes the expansion of metastasis-initiating cells in breast cancer
Bousquenaud, M. and Fico, F. and Solinas, G. and Ruegg, C. and Santamaria-Martinez, A.,
20.1
, 104
| Article
Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits
Boylan, A. M. and Ruegg, C. and Kim, K. J. and Hebert, C. A. and Hoeffel, J. M. and Pytela, R. and Sheppard, D. and Goldstein, I. M. and Broaddus, V. C.,
89.4
, 1257–67
| Article
c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells
Brembilla, N. C. and Weber, J. and Rimoldi, D. and Pradervand, S. and Schutz, F. and Pantaleo, G. and Ruegg, C. and Quadroni, M. and Harshman, K. and Doucey, M. A.,
112.3
, 652–60
| Article
Profiling of T-cell receptor signaling complex assembly in human CD4 T-lymphocytes using RP protein arrays
Brembilla, N. C. and Cohen-Salmon, I. and Weber, J. and Ruegg, C. and Quadroni, M. and Harshman, K. and Doucey, M. A.,
9.2
, 299–309
| Article
Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs
Calzascia, T. and Masson, F. and Di Berardino-Besson, W. and Contassot, E. and Wilmotte, R. and Aurrand-Lions, M. and Ruegg, C. and Dietrich, P. Y. and Walker, P. R.,
22.2
, 175–84
| Article
Not just Fundamental Research: Education, Equal Opportunities, Knowledge and Technology Transfer, and Communication at the NCCR Bio-Inspired Materials
Capper, S. and Haskal, E. and Kilbinger, A. and de Espinosa, L. M. and Rothen-Rutishauser, B. and Ruegg, C. and Weder, C.,
73.1
, 86–89
| Article
MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells
Carrascosa, C. and Obula, R. G. and Missiaglia, E. and Lehr, H. A. and Delorenzi, M. and Frattini, M. and Ruegg, C. and Mariotti, A.,
31.12
, 1521–32
| Article
Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients
Cattin, S. and Fellay, B. and Pradervand, S. and Trojan, A. and Ruhstaller, T. and Ruegg, C. and Furstenberger, G.,
7.10
, 11137–50
| Article
Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells
Chouaib, S. and Kieda, C. and Benlalam, H. and Noman, M. Z. and Mami-Chouaib, F. and Ruegg, C.,
30.6
, 529–45
| Article
Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer
Ciarloni, L. and Ehrensberger, S. H. and Imaizumi, N. and Monnier-Benoit, S. and Nichita, C. and Myung, S. J. and Kim, J. S. and Song, S. Y. and Kim, T. I. and van der Weg, B. and Meier, R. and Borovicka, J. and Beglinger, C. and Vallet, C. and Maerten, P. and Ruegg, C. and Dorta, G.,
22.18
, 4604–11
| Article
Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR
Ciarloni, L. and Hosseinian, S. and Monnier-Benoit, S. and Imaizumi, N. and Dorta, G. and Ruegg, C. and Group, Dgnp-Col- Study,
10.4
, e0123904
| Article
Metabolic labeling and protein linearization technology allow the study of proteins secreted by cultured cells in serum-containing media
Colzani, M. and Waridel, P. and Laurent, J. and Faes, E. and Ruegg, C. and Quadroni, M.,
8.10
, 4779–88
| Article
Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients
Degen, M. and Brellier, F. and Schenk, S. and Driscoll, R. and Zaman, K. and Stupp, R. and Tornillo, L. and Terracciano, L. and Chiquet-Ehrismann, R. and Ruegg, C. and Seelentag, W.,
122.11
, 2454–61
| Article
Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives
Dermond, O. and Ruegg, C.,
4.5
, 314–21
| Article
Manganese-induced integrin affinity maturation promotes recruitment of alpha V beta 3 integrin to focal adhesions in endothelial cells: evidence for a role of phosphatidylinositol 3-kinase and Src
Dormond, O. and Ponsonnet, L. and Hasmim, M. and Foletti, A. and Ruegg, C.,
92.1
, 151–61
| Article
NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis
Dormond, O. and Foletti, A. and Paroz, C. and Ruegg, C.,
7.9
, 1041–7
| Article
Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling
Dormond, O. and Bezzi, M. and Mariotti, A. and Ruegg, C.,
277.48
, 45838–46
| Article
Regulation of endothelial cell integrin function and angiogenesis by COX-2, cAMP and Protein Kinase A
Dormond, O. and Ruegg, C.,
90.4
, 577–85
| Article
The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation
Doucey, M. A. and Legler, D. F. and Faroudi, M. and Boucheron, N. and Baumgaertner, P. and Naeher, D. and Cebecauer, M. and Hudrisier, D. and Ruegg, C. and Palmer, E. and Valitutti, S. and Bron, C. and Luescher, I. F.,
278.29
, 26983–91
| Article
Novel integrin alpha and beta subunit cDNAs identified in airway epithelial cells and lung leukocytes using the polymerase chain reaction
Erle, D. J. and Sheppard, D. and Breuss, J. and Ruegg, C. and Pytela, R.,
5.2
, 170–7
| Article
An immature B cell population from peripheral blood serves as surrogate marker for monitoring tumor angiogenesis and anti-angiogenic therapy in mouse models
Fagiani, E. and Bill, R. and Pisarsky, L. and Ivanek, R. and Ruegg, C. and Christofori, G.,
18.3
, 327–45
| Article
Breast Cancer Stem Cells with Tumor- versus Metastasis-Initiating Capacities Are Modulated by TGFBR1 Inhibition
Fico, F. and Bousquenaud, M. and Ruegg, C. and Santamaria-Martinez, A.,
13.1
, 1–9
| Article
Computational modeling of shear forces and experimental validation of endothelial cell responses in an orbital well shaker system
Filipovic, N. and Ghimire, K. and Saveljic, I. and Milosevic, Z. and Ruegg, C.,
19.6
, 581–90
| Article
Isolated integrin beta3 subunit cytoplasmic domains require membrane anchorage and the NPXY motif to recruit to adhesion complexes but do not discriminate between beta1- and beta3-positive complexes
Foletti, A. and Alghisi, G. C. and Ponsonnet, L. and Ruegg, C.,
94.1
, 155–66
| Article
Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARalpha mediated mechanism
Garrido-Urbani, S. and Jemelin, S. and Deffert, C. and Carnesecchi, S. and Basset, O. and Szyndralewiez, C. and Heitz, F. and Page, P. and Montet, X. and Michalik, L. and Arbiser, J. and Ruegg, C. and Krause, K. H. and Imhof, B. A.,
6.2
, e14665
| Article
Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion
Gerain, J. and Lienard, D. and Pampallona, S. and Baumgartner, M. and Ruegg, C. and Buurman, W. A. and Eggermont, A. and Lejeune, F.,
9.12
, 1034–42
| Article
Angiogenic activity of breast cancer patients' monocytes reverted by combined use of systems modeling and experimental approaches
Guex, N. and Crespo, I. and Bron, S. and Ifticene-Treboux, A. and Faes-Van't Hull, E. and Kharoubi, S. and Liechti, R. and Werffeli, P. and Ibberson, M. and Majo, F. and Nicolas, M. and Laurent, J. and Garg, A. and Zaman, K. and Lehr, H. A. and Stevenson, B. J. and Ruegg, C. and Coukos, G. and Delaloye, J. F. and Xenarios, I. and Doucey, M. A.,
11.3
, e1004050
| Article
Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways
Hasmim, M. and Bieler, G. and Ruegg, C.,
5.1
, 166–73
| Article
Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin
Hauzenberger, D. and Olivier, P. and Gundersen, D. and Ruegg, C.,
29.5
, 1435–47
| Article
The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression
Huang, Y. T. and Lan, Q. and Ponsonnet, L. and Blanquet, M. and Christofori, G. and Zaric, J. and Ruegg, C.,
7.2
, 1663–74
| Article
The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis
Huang, Y. T. and Lan, Q. and Lorusso, G. and Duffey, N. and Ruegg, C.,
8.6
, 9200–9215
| Article
Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting
Imaizumi, N. and Monnier, Y. and Hegi, M. and Mirimanoff, R. O. and Ruegg, C.,
5.6
, e11084
| Article
Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis
Irmler, M. and Steiner, V. and Ruegg, C. and Wajant, H. and Tschopp, J.,
468.2
, 129–33
| Article
Fibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin alphavbeta5-mediated adhesion
Knuchel, S. and Anderle, P. and Werfelli, P. and Diamantis, E. and Ruegg, C.,
6.16
, 14300–17
| Article
Fc block treatment, dead cells exclusion, and cell aggregates discrimination concur to prevent phenotypical artifacts in the analysis of subpopulations of tumor-infiltrating CD11b(+) myelomonocytic cells
Kuonen, F. and Touvrey, C. and Laurent, J. and Ruegg, C.,
77.11
, 1082–90
| Article
Inhibition of the Kit ligand/c-Kit axis attenuates metastasis in a mouse model mimicking local breast cancer relapse after radiotherapy
Kuonen, F. and Laurent, J. and Secondini, C. and Lorusso, G. and Stehle, J. C. and Rausch, T. and Faes-Van't Hull, E. and Bieler, G. and Alghisi, G. C. and Schwendener, R. and Andrejevic-Blant, S. and Mirimanoff, R. O. and Ruegg, C.,
18.16
, 4365–74
| Article
Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment
Kuonen, F. and Secondini, C. and Ruegg, C.,
18.19
, 5196–202
| Article
TGFbeta, Fibronectin and Integrin alpha5beta1 Promote Invasion in Basal Cell Carcinoma
Kuonen, F. and Surbeck, I. and Sarin, K. Y. and Dontenwill, M. and Ruegg, C. and Gilliet, M. and Oro, A. E. and Gaide, O.,
138.11
, 2432–2442
| Article
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
Lan, Q. and Peyvandi, S. and Duffey, N. and Huang, Y. T. and Barras, D. and Held, W. and Richard, F. and Delorenzi, M. and Sotiriou, C. and Desmedt, C. and Lorusso, G. and Ruegg, C.,
38.15
, 2814–2829
| Article
Emerging paradigms and questions on pro-angiogenic bone marrow-derived myelomonocytic cells
Laurent, J. and Touvrey, C. and Botta, F. and Kuonen, F. and Ruegg, C.,
55.4
, 527–34
| Article
Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors
Laurent, J. and Hull, E. F. and Touvrey, C. and Kuonen, F. and Lan, Q. and Lorusso, G. and Doucey, M. A. and Ciarloni, L. and Imaizumi, N. and Alghisi, G. C. and Fagiani, E. and Zaman, K. and Stupp, R. and Shibuya, M. and Delaloye, J. F. and Christofori, G. and Ruegg, C.,
71.11
, 3781–91
| Article
Clinical applications of TNF-alpha in cancer
Lejeune, F. J. and Ruegg, C. and Lienard, D.,
10.5
, 573–80
| Article
Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor
Lejeune, F. J. and Monnier, Y. and Ruegg, C.,
16.3
, 263–5
| Article
Soft tissue sarcoma therapy: prospects for future studies
Lejeune, F. J. and Lienard, D. and Ruegg, C. and Leyvraz, S.,
21.5
, 474–7
| Article
Thy-1 binds to integrin beta(3) on astrocytes and triggers formation of focal contact sites
Leyton, L. and Schneider, P. and Labra, C. V. and Ruegg, C. and Hetz, C. A. and Quest, A. F. and Bron, C.,
11.13
, 1028–38
| Article
New insights into the mechanisms of organ-specific breast cancer metastasis
Lorusso, G. and Ruegg, C.,
22.3
, 226–33
| Article
The tumor microenvironment and its contribution to tumor evolution toward metastasis
Lorusso, G. and Ruegg, C.,
130.6
, 1091–103
| Article
Ataxia telangiectasia mutated (ATM) inhibition transforms human mammary gland epithelial cells
Mandriota, S. J. and Buser, R. and Lesne, L. and Stouder, C. and Favaudon, V. and Maechler, P. and Bena, F. and Clement, V. and Ruegg, C. and Montesano, R. and Sappino, A. P.,
285.17
, 13092–106
| Article
N-cadherin as a therapeutic target in cancer
Mariotti, A. and Perotti, A. and Sessa, C. and Ruegg, C.,
16.4
, 451–65
| Article
Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro
Martina, E. and Degen, M. and Ruegg, C. and Merlo, A. and Lino, M. M. and Chiquet-Ehrismann, R. and Brellier, F.,
24.3
, 778–87
| Article
The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion
Meier, R. and Muhlethaler-Mottet, A. and Flahaut, M. and Coulon, A. and Fusco, C. and Louache, F. and Auderset, K. and Bourloud, K. B. and Daudigeos, E. and Ruegg, C. and Vassal, G. and Gross, N. and Joseph, J. M.,
2.10
, e1016
| Article
Synthesis and in vitro evaluation of a novel radioligand for alphavbeta3 integrin receptor imaging: [18F]FPPA-c(RGDfK)
Monaco, A. and Zoete, V. and Alghisi, G. C. and Ruegg, C. and Michelin, O. and Prior, J. and Scapozza, L. and Seimbille, Y.,
23.22
, 6068–72
| Article
Synthesis of a non-peptidic PET tracer designed for alpha5beta1 integrin receptor
Monaco, A. and Michelin, O. and Prior, J. and Ruegg, C. and Scapozza, L. and Seimbille, Y.,
57.5
, 365–70
| Article
CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma
Monnier, Y. and Farmer, P. and Bieler, G. and Imaizumi, N. and Sengstag, T. and Alghisi, G. C. and Stehle, J. C. and Ciarloni, L. and Andrejevic-Blant, S. and Moeckli, R. and Mirimanoff, R. O. and Goodman, S. L. and Delorenzi, M. and Ruegg, C.,
68.18
, 7323–31
| Article
Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back
Monnier, Y. and Zaric, J. and Ruegg, C.,
4.1
, 31–8
| Article
Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia
Murat, A. and Migliavacca, E. and Hussain, S. F. and Heimberger, A. B. and Desbaillets, I. and Hamou, M. F. and Ruegg, C. and Stupp, R. and Delorenzi, M. and Hegi, M. E.,
4.6
, e5947
| Article
A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer
Nichita, C. and Ciarloni, L. and Monnier-Benoit, S. and Hosseinian, S. and Dorta, G. and Ruegg, C.,
39.5
, 507–17
| Article
Disruption of integrin-dependent adhesion and survival of endothelial cells by recombinant adenovirus expressing isolated beta integrin cytoplasmic domains
Oguey, D. and George, P. W. and Ruegg, C.,
7.15
, 1292–303
| Article
Urokinase-type plasminogen activator inhibits alpha 4 beta 1 integrin-mediated T lymphocyte adhesion to fibronectin independently of its catalytic activity
Olivier, P. and Bieler, G. and Muller, K. M. and Hauzenberger, D. and Ruegg, C.,
29.10
, 3196–209
| Article
Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle
Palmer, E. L. and Ruegg, C. and Ferrando, R. and Pytela, R. and Sheppard, D.,
123.5
, 1289–97
| Article
Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587
Peng, S. B. and Van Horn, R. D. and Yin, T. and Brown, R. M. and Roell, W. C. and Obungu, V. H. and Ruegg, C. and Wroblewski, V. J. and Raddad, E. and Stille, J. R.,
8.55
, 94619–94634
| Article
Baicalein inhibits acinar-to-ductal metaplasia of pancreatic acinal cell AR42J via improving the inflammatory microenvironment
Pu, W. L. and Luo, Y. Y. and Bai, R. Y. and Guo, A. W. and Zhou, K. and Zhang, Y. S. and Miao, L. and Ruegg, C. and Hottiger, M. O. and Gao, X. M. and Sun, L. K.,
233.8
, 5747–5755
| Article
Targeting tumor-associated macrophages by anti-tumor Chinese materia medica
Pu, W. L. and Sun, L. K. and Gao, X. M. and Ruegg, C. and Cuendet, M. and Hottiger, M. O. and Zhou, K. and Miao, L. and Zhang, Y. S. and Gebauer, M.,
23.10
, 723–732
| Article
The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production
Puente Navazo, M. D. and Valmori, D. and Ruegg, C.,
167.11
, 6431–40
| Article
Compartmentalization in membrane rafts defines a pool of N-cadherin associated with catenins and not engaged in cell-cell junctions in melanoma cells
Rossier-Pansier, L. and Baruthio, F. and Ruegg, C. and Mariotti, A.,
103.3
, 957–71
| Article
Antiangiogenic peptides and proteins: from experimental tools to clinical drugs
Ruegg, C. and Hasmim, M. and Lejeune, F. J. and Alghisi, G. C.,
1765.2
, 155–77
| Article
A Bio-Inspired Amplification Cascade for the Detection of Rare Cancer Cells
Ruegg, C. and Reis, C. and Rafiee, S. and Rodriguez-Lorenzo, L. and List, J. and Rothen-Rutishauser, B. and Mayer, M. and Petri-Fink, A.,
73.1
, 63–68
| Article
Characterization of the leukocyte integrin subunit beta 7
Ruegg, C. and Pytela, R. and Erle, D. J.,
103.2
, 86S
| Article
Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis
Ruegg, C. and Dormond, O. and Mariotti, A.,
1654.1
, 51–67
| Article
Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
Ruegg, C. and Yilmaz, A. and Bieler, G. and Bamat, J. and Chaubert, P. and Lejeune, F. J.,
4.4
, 408–14
| Article
Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions
Ruegg, C.,
80.4
, 682–4
| Article
Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality
Ruegg, C. and Zaric, J. and Stupp, R.,
35.7
, 476–87
| Article
The quest for surrogate markers of angiogenesis: a paradigm for translational research in tumor angiogenesis and anti-angiogenesis trials
Ruegg, C. and Meuwly, J. Y. and Driscoll, R. and Werffeli, P. and Zaman, K. and Stupp, R.,
3.8
, 673–91
| Article
Radiation-induced modifications of the tumor microenvironment promote metastasis
Ruegg, C. and Monnier, Y. and Kuonen, F. and Imaizumi, N.,
98.6
, 47–57
| Article
Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering
Ruegg, C. and Postigo, A. A. and Sikorski, E. E. and Butcher, E. C. and Pytela, R. and Erle, D. J.,
117.1
, 179–89
| Article
Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein
Ruegg, C. and Pytela, R.,
160.2
, 257–62
| Article
Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target?
Ruegg, C. and Dormond, O. and Foletti, A.,
9.3
, 151–60
| Article
Tenascin, an extracellular matrix protein, exerts immunomodulatory activities
Ruegg, C. R. and Chiquet-Ehrismann, R. and Alkan, S. S.,
86.19
, 7437–41
| Article
Thalidomide in small cell lung cancer: wrong drug or wrong disease?
Ruegg, C. and Peters, S.,
101.15
, 1034–5
| Article
Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis
Ruegg, C. and Mariotti, A.,
60.6
, 1135–57
| Article
Rapid increase in plasma tenascin-C concentration after isolated limb perfusion with high-dose tumor necrosis factor (TNF), interferon gamma (IFN gamma) and melphalan for regionally advanced tumors
Schienk, S. and Lienard, D. and Gerain, J. and Baumgartner, M. and Lejeune, F. J. and Chiquet-Ehrismann, R. and Ruegg, C.,
63.5
, 665–72
| Article
Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix
Schlaeppi, M. and Ruegg, C. and Tran-Thang, C. and Chapuis, G. and Tevaearai, H. and Lahm, H. and Sordat, B.,
4.6
, 439–55
| Article
Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade
Secondini, C. and Coquoz, O. and Spagnuolo, L. and Spinetti, T. and Peyvandi, S. and Ciarloni, L. and Botta, F. and Bourquin, C. and Ruegg, C.,
6.6
, e1316437
| Article
Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
Sessa, C. and Guibal, A. and Del Conte, G. and Ruegg, C.,
5.7
, 378–91
| Article
Concepts of metastasis in flux: the stromal progression model
Sleeman, J. P. and Christofori, G. and Fodde, R. and Collard, J. G. and Berx, G. and Decraene, C. and Ruegg, C.,
22.3
, 174–86
| Article
Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis
Sofia Vala, I. and Martins, L. R. and Imaizumi, N. and Nunes, R. J. and Rino, J. and Kuonen, F. and Carvalho, L. M. and Ruegg, C. and Grillo, I. M. and Barata, J. T. and Mareel, M. and Santos, S. C.,
5.6
, e11222
| Article
TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
Spinetti, T. and Spagnuolo, L. and Mottas, I. and Secondini, C. and Treinies, M. and Ruegg, C. and Hotz, C. and Bourquin, C.,
5.11
, e1230578
| Article
Integrin inhibitors reaching the clinic
Stupp, R. and Ruegg, C.,
25.13
, 1637–8
| Article
Targeting integrins in malignant glioma
Tabatabai, G. and Weller, M. and Nabors, B. and Picard, M. and Reardon, D. and Mikkelsen, T. and Ruegg, C. and Stupp, R.,
5.3
, 175–81
| Article
The alphaVbeta3/alphaVbeta5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model
Ten Hagen, T. L. and Seynhaeve, A. L. and de Wiel-Ambagtsheer, Ga and de Bruijn, E. A. and van Tiel, S. T. and Ruegg, C. and Meyring, M. and Grell, M. and Goodman, S. L. and Eggermont, A. M.,
132.11
, 2694–704
| Article
Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion
Villard, V. and Kalyuzhniy, O. and Riccio, O. and Potekhin, S. and Melnik, T. N. and Kajava, A. V. and Ruegg, C. and Corradin, G.,
12.3
, 206–12
| Article
Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-beta signaling axes
Xue, G. and Restuccia, D. F. and Lan, Q. and Hynx, D. and Dirnhofer, S. and Hess, D. and Ruegg, C. and Hemmings, B. A.,
2.3
, 248–59
| Article
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition
Xue, G. and Kohler, R. and Tang, F. and Hynx, D. and Wang, Y. and Orso, F. and Pretre, V. and Ritschard, R. and Hirschmann, P. and Cron, P. and Roloff, T. and Dummer, R. and Mandala, M. and Bichet, S. and Genoud, C. and Meyer, A. G. and Muraro, M. G. and Spagnoli, G. C. and Taverna, D. and Ruegg, C. and Merghoub, T. and Massi, D. and Tang, H. and Levesque, M. P. and Dirnhofer, S. and Zippelius, A. and Hemmings, B. A. and Wicki, A.,
8.41
, 69204–69218
| Article
Pulse treatment of human vascular endothelial cells with high doses of tumor necrosis factor and interferon-gamma results in simultaneous synergistic and reversible effects on proliferation and morphology
Yilmaz, A. and Bieler, G. and Spertini, O. and Lejeune, F. J. and Ruegg, C.,
77.4
, 592–9
| Article
Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy
Zaman, K. and Driscoll, R. and Hahn, D. and Werffeli, P. and Goodman, S. L. and Bauer, J. and Leyvraz, S. and Lejeune, F. and Stupp, R. and Ruegg, C.,
118.3
, 755–64
| Article
Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells
Zaric, J. and Joseph, J. M. and Tercier, S. and Sengstag, T. and Ponsonnet, L. and Delorenzi, M. and Ruegg, C.,
31.1
, 48–59
| Article
Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation
Zaric, J. and Ruegg, C.,
280.2
, 1077–85
| Article
Myeloid cells contribute to tumor lymphangiogenesis
Zumsteg, A. and Baeriswyl, V. and Imaizumi, N. and Schwendener, R. and Ruegg, C. and Christofori, G.,
4.9
, e7067
| Article
Ultrasensitive detection of cancer-associated nucleic acids and mutations by primer exchange reaction-based signal amplification and flow cytometry
Kocabey, Samet and Cattin, Sarah and Gray, Isabelle and Rüegg, Curzio,
267
, 116839
| Article
Establishing and Characterizing Chemotherapy-Induced Immunological Dormant Tumor Cell Lines
Q, Lan and S, Peyvandi and C, Rüegg,
2811
| Article
Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis
Zhang, Yunsha and Pu, Weiling and Bousquenaud, Mélanie and Cattin, Sarah and Zaric, Jelena and Sun, Li-kang and Rüegg, Curzio,
10
| Article
Circulating immune cell populations related to primary breast cancer, surgical removal, and radiotherapy revealed by flow cytometry analysis
Cattin, Sarah and Fellay, Benoît and Calderoni, Antonello and Christinat, Alexandre and Negretti, Laura and Biggiogero, Maira and Badellino, Alberto and Schneider, Anne-Lise and Tsoutsou, Pelagia and Pellanda, Alessandra Franzetti and Rüegg, Curzio,
23.1
, 64
| Article
Natural and Modified Oligonucleotide Sequences Show Distinct Strand Displacement Kinetics and These Are Affected Further by Molecular Crowders
Domljanovic, Ivana and Ianiro, Alessandro and Rüegg, Curzio and Mayer, Michael and Taskova, Maria,
12.9
, 1249
| Article
Mathematical modeling approach of cancer immunoediting reveals new insights in targeted-therapy and timing plan of cancer treatment
Ghanizadeh, Mojtaba and Shariatpanahi, Seyed Peyman and Goliaei, Bahram and Rüegg, Curzio,
152
, 111349
| Article
Ultrasensitive and multiplexed miRNA detection system with DNA-PAINT
Kocabey, Samet and Chiarelli, Germán and Acuna, Guillermo P. and Ruegg, Curzio,
224
, 115053
| Article
Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation
Lorusso, Girieca and Wyss, Christof B. and Kuonen, François and Vannini, Nicola and Billottet, Clotilde and Duffey, Nathalie and Pineau, Raphael and Lan, Qiang and Wirapati, Pratyaksha and Barras, David and Tancredi, Alessandro and Lyck, Ruth and Lehr, Hans-Anton and Engelhardt, Britta and Delorenzi, Mauro and Bikfalvi, Andreas and Rüegg, Curzio,
14.661
, eaax8933
| Article
Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
Lorusso, Girieca and Rüegg, Curzio and Kuonen, François,
10
| Article
Dormant Tumor Cell Vaccination: A Mathematical Model of Immunological Dormancy in Triple-Negative Breast Cancer
Mehdizadeh, Reza and Shariatpanahi, Seyed Peyman and Goliaei, Bahram and Peyvandi, Sanam and Rüegg, Curzio,
13.2
| Article
Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK-induced cancer cell plasticity
S, Peyvandi and M, Bulliard and A, Yilmaz and A, Kauzlaric and R, Marcone and L, Haerri and O, Coquoz and Yt, Huang and N, Duffey and L, Gafner and G, Lorusso and N, Fournier and Q, Lan and C, Rüegg,
134.6
| Article
MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER+ Breast Cancer
Wörthmüller, Janine and Disler, Simona and Pradervand, Sylvain and Richard, François and Haerri, Lisa and Ruiz Buendía, Gustavo A. and Fournier, Nadine and Desmedt, Christine and Rüegg, Curzio,
12.15
, 1929
| Article
MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer
Alday-Parejo, Begoña and Richard, François and Wörthmüller, Janine and Rau, Tilman and Galván, José A. and Desmedt, Christine and Santamaria-Martinez, Albert and Rüegg, Curzio,
12.1
, 223
| Article
MAGI1 localizes to mature focal adhesion and modulates endothelial cell adhesion, migration and angiogenesis
Alday-Parejo, Begoña and Ghimire, Kedar and Coquoz, Oriana and Albisetti, Gioele W. and Tamò, Luca and Zaric, Jelena and Stalin, Jimmy and Rüegg, Curzio,
15.1
, 126–139
| Article
DNA origami book biosensor for multiplex detection of cancer-associated nucleic acids
Domljanovic, Ivana and Loretan, Morgane and Kempter, Susanne and Acuna, Guillermo P. and Kocabey, Samet and Ruegg, Curzio,
14.41
, 15432–15441
| Article
CD47 Promotes Age-Associated Deterioration in Angiogenesis, Blood Flow and Glucose Homeostasis
Ghimire, Kedar and Li, Yao and Chiba, Takuto and Julovi, Sohel M. and Li, Jennifer and Ross, Mark A. and Straub, Adam C. and O’Connell, Philip J. and Rüegg, Curzio and Pagano, Patrick J. and Isenberg, Jeffrey S. and Rogers, Natasha M.,
9.7
, 1695
| Article
Membrane-Interacting DNA Nanotubes Induce Cancer Cell Death
Kocabey, Samet and Ekim Kocabey, Aslihan and Schneiter, Roger and Rüegg, Curzio,
11.8
, 2003
| Article
Detection of HER2+ Breast Cancer Cells using Bioinspired DNA-Based Signal Amplification
Rafiee, Sarah D. and Kocabey, Samet and Mayer, Michael and List, Jonathan and Rüegg, Curzio,
15.8
, 661–666
| Article
Polymersomes-Mediated Delivery of CSF1R Inhibitor to Tumor Associated Macrophages Promotes M2 to M1-Like Macrophage Repolarization
Rodriguez-Perdigon, Manuel and Jimaja, Sètuhn and Haeni, Laetitia and Bruns, Nico and Rothen-Rutishauser, Barbara and Rüegg, Curzio,
22.8
, 2200168
| Article
Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy
Stalin, Jimmy and Imhof, Beat A. and Coquoz, Oriana and Jeitziner, Rachel and Hammel, Philippe and McKee, Thomas A. and Jemelin, Stephane and Poittevin, Marine and Pocard, Marc and Matthes, Thomas and Kaci, Rachid and Delorenzi, Mauro and Rüegg, Curzio and Miljkovic-Licina, Marijana,
13.18
, 4625
| Article
Recent Anti-angiogenic Drug Discovery Efforts To Combat Cancer
Upadhyay, Neha and Tilekar, Kalpana and Safuan, Sabreena and Kumar, Alan P. and Stalin, Jimmy and Ruegg, Curzio and S, Ramaa C.,
6.23
, 5689–5700
| Article
The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
Wörthmüller, Janine and Rüegg, Curzio,
21.23
, 9107
| Article
MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions
Wörthmüller, Janine and Rüegg, Curzio,
10.6
, 1494
| Article
Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint Blockade
Safaeifard, Fateme and Goliaei, Bahram and Aref, Amir R. and Foroughmand-Araabi, Mohammad-Hadi and Goliaei, Sama and Lorch, Jochen and Jenkins, Russell W. and Barbie, David A. and Shariatpanahi, Seyed Peyman and Rüegg, Curzio,
11.22
, 3534
| Article
Gain of HIF1 Activity and Loss of miRNA let-7d Promote Breast Cancer Metastasis to the Brain via the PDGF/PDGFR Axis
Wyss, Christof B. and Duffey, Nathalie and Peyvandi, Sanam and Barras, David and Usatorre, Amaïa Martinez and Coquoz, Oriana and Romero, Pedro and Delorenzi, Mauro and Lorusso, Girieca and Rüegg, Curzio,
81.3
, 594–605
| Article
Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment
Mehdizadeh, Reza and Shariatpanahi, Seyed Peyman and Goliaei, Bahram and Rüegg, Curzio,
13.1
, 5875
| Article
